Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Research Award: Canada Graduate Scholarships

McMaster University

$105,000.00

Macrophage phenotyping in lung fibrosis and cancer: Identification of shared markers and therapeutic targets to prevent progression of disease

EF 2021-22

Résumé
Often, understanding how a disease develops and progresses on the cellular level is a key step in developing cures and preventative measures. In our research laboratory, we work on a specific type of immune cells called macrophages, that is often associated with many different diseases. We believe that changing the way these macrophages behave will slow down the progression of these diseases. In the proposed work, I plan to compare macrophages across several known lung diseases that currently have very few good treatment options. Further, we believe that one specific subtype of macrophages are present in these various lung diseases. Identifying and targeting that one subtype of macrophage could help develop treatments for a wide range of lung diseases. However, before we can do this, we need to confirm the presence and characteristics of this macrophage subtype. We plan to do this by comparing and contrasting the presence and behaviour of macrophages in lung tissues derived from patients. These tissues can come from patients that do not have any specific disease (as controls), patients diagnosed with lung cancer, patients diagnosed with Idiopathic Pulmonary Fibrosis (a disease where lungs become scarred over time, making it difficult to breathe) and patients diagnosed with Pulmonary Langerhans Cell Histiocytosis (a rare lung disease that develops both tumors and scarring). Once we have identified these "bad" macrophages, we will examine ways of modulating their behavior using cellular systems and assays that are already established in our laboratory. To do this work, we have assembled a multidisciplinary team of molecular scientists, clinicians, pathologists, bioinformaticians and chemists that will work together to not only identify these macrophages but provide context and resources to continue this work to better provide novel treatment options for several different chronic lung diseases.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
458584
Name
Naiel Safaa
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Macrophage phenotyping in lung fibrosis and cancer: Identification of shared markers and therapeutic targets to prevent progression of disease
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Alternatively-Activated Macrophages; Animal Models; Disease Characterization; Human Tissues; Lung Cancer; Lung Fibrosis; Lung Physiology; Macrophages; Therapeutic Intervention; Tumour-Associated Macrophages
Abstract
Often, understanding how a disease develops and progresses on the cellular level is a key step in developing cures and preventative measures. In our research laboratory, we work on a specific type of immune cells called macrophages, that is often associated with many different diseases. We believe that changing the way these macrophages behave will slow down the progression of these diseases. In the proposed work, I plan to compare macrophages across several known lung diseases that currently have very few good treatment options. Further, we believe that one specific subtype of macrophages are present in these various lung diseases. Identifying and targeting that one subtype of macrophage could help develop treatments for a wide range of lung diseases. However, before we can do this, we need to confirm the presence and characteristics of this macrophage subtype. We plan to do this by comparing and contrasting the presence and behaviour of macrophages in lung tissues derived from patients. These tissues can come from patients that do not have any specific disease (as controls), patients diagnosed with lung cancer, patients diagnosed with Idiopathic Pulmonary Fibrosis (a disease where lungs become scarred over time, making it difficult to breathe) and patients diagnosed with Pulmonary Langerhans Cell Histiocytosis (a rare lung disease that develops both tumors and scarring). Once we have identified these "bad" macrophages, we will examine ways of modulating their behavior using cellular systems and assays that are already established in our laboratory. To do this work, we have assembled a multidisciplinary team of molecular scientists, clinicians, pathologists, bioinformaticians and chemists that will work together to not only identify these macrophages but provide context and resources to continue this work to better provide novel treatment options for several different chronic lung diseases.
Competitiondate
202111
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Naiel, Safaa
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~